Conclusive clinical evidence, however, has not been established since different studies in type 1 DM reported heterogeneous results, with a tendency towards an increase in TGF-β serum levels with the duration of diabetes and its microvascular complications [40, 41]. Here, TGFB1 is linked to diabetes mellitus.